These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3665696)

  • 1. First-order Wiener kernel visually evoked potentials obtained from multiple sclerosis patients.
    Schoon DV; Wong EK
    Doc Ophthalmol; 1987 Jan; 65(1):125-34. PubMed ID: 3665696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern visual evoked potentials and spatial vision in retrobulbar neuritis and multiple sclerosis.
    Neima D; Regan D
    Arch Neurol; 1984 Feb; 41(2):198-201. PubMed ID: 6691824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
    Grecescu M
    J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acuity estimated by visually evoked potentials is affected by scaling.
    Chan H; Odom JV; Coldren J; Dove C; Chao GM
    Doc Ophthalmol; 1986 Jan; 62(1):107-17. PubMed ID: 3956352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation of evoked potentials and visual preference in 6-45-day-old infants: effects of check size, visual acuity, and refractive error.
    Harter MR; Deaton FK; Odom JV
    Electroencephalogr Clin Neurophysiol; 1977 May; 42(5):595-607. PubMed ID: 67021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
    Di Maggio G; Santangelo R; Guerrieri S; Bianco M; Ferrari L; Medaglini S; Rodegher M; Colombo B; Moiola L; Chieffo R; Del Carro U; Martinelli V; Comi G; Leocani L
    Mult Scler; 2014 Sep; 20(10):1342-7. PubMed ID: 24591532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in the first order Weiner kernel visual evoked potential.
    Schoon DV; Enomoto H; Harris MP
    Doc Ophthalmol; 1989 Mar; 71(3):329-40. PubMed ID: 2776635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 20/20 eye in multiple sclerosis.
    Kupersmith MJ; Nelson JI; Seiple WH; Carr RE; Weiss PA
    Neurology; 1983 Aug; 33(8):1015-20. PubMed ID: 6683795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
    Taş A; Cakir Gundogan F; Akgun H; Erdem U; Sobaci G
    Med Glas (Zenica); 2013 Feb; 10(1):99-105. PubMed ID: 23348170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Objective assessment of visual acuity with visual evoked potential].
    Yu M; Wu DZ; Liang J; Wu L
    Yan Ke Xue Bao; 1997 Jun; 13(2):59-61. PubMed ID: 11189334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern reversal visual evoked response and Snellen visual acuity.
    Katsumi O; Mehta MC; Larson-Park EW; Skladzien CJ; Hirose T
    Graefes Arch Clin Exp Ophthalmol; 1994 May; 232(5):272-8. PubMed ID: 8045436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
    Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
    Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of pattern reversal visual evoked potentials P100 with visual acuity].
    Li QQ; Liu XQ; Chen XP
    Fa Yi Xue Za Zhi; 2011 Apr; 27(2):91-3, 101. PubMed ID: 21604444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trial on the objective evaluation of visual acuity and its maturation by the method of evoked visual potentials].
    Marechal L; Faidherbe J
    Arch Int Physiol Biochim; 1990 Apr; 98(2):TD1-96. PubMed ID: 1695084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased amplitudes in multiple sclerosis patients with normal visual acuity: a VEP study.
    Diem R; Tschirne A; Bähr M
    J Clin Neurosci; 2003 Jan; 10(1):67-70. PubMed ID: 12464525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miniature fiber-optic pattern-reversal stimulator for determination of the visual evoked potential threshold; comparison with Snellen acuity.
    Raniel Y; Pratt H; Neumann E; Schacham SE
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(3):212-5. PubMed ID: 2737481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visual evoked potentials elicited by pseudorandom stimulation in macular degeneration].
    Nemoto N; Mori H; Kiyosawa M; Wang WF; Mochizuki M; Momose K
    Nippon Ganka Gakkai Zasshi; 2001 May; 105(5):326-32. PubMed ID: 11406949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual acuity prediction using the VER--temporal aspects.
    Douthwaite WA; Jenkins TC; Taylor AJ
    Am J Optom Physiol Opt; 1987 Dec; 64(12):888-96. PubMed ID: 3445882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
    Parisi V; Manni G; Spadaro M; Colacino G; Restuccia R; Marchi S; Bucci MG; Pierelli F
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An objective VER assessment of visual acuity compared with subjective measures.
    Jenkins TC; Douthwaite WA
    Am J Optom Physiol Opt; 1988 Dec; 65(12):957-61. PubMed ID: 3223510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.